Esken Limited
ESKNF · OTC
2/28/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Revenue | $120 | $105 | $111 | $170 |
| % Growth | 14.7% | -5.5% | -34.9% | – |
| Cost of Goods Sold | $117 | $77 | $107 | $120 |
| Gross Profit | $3 | $28 | $3 | $50 |
| % Margin | 2.8% | 26.6% | 3% | 29.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $3 | $2 | $0 |
| SG&A Expenses | $3 | $3 | $2 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $14 | $111 | $160 | $184 |
| Operating Expenses | $17 | $115 | $160 | $184 |
| Operating Income | -$14 | -$8 | -$157 | -$19 |
| % Margin | -11.4% | -7.7% | -141.7% | -11.1% |
| Other Income/Exp. Net | -$14 | -$20 | -$18 | -$12 |
| Pre-Tax Income | -$28 | -$35 | -$150 | -$158 |
| Tax Expense | -$3 | -$10 | -$7 | -$8 |
| Net Income | -$25 | -$25 | -$143 | -$150 |
| % Margin | -21% | -23.6% | -129.4% | -87.9% |
| EPS | -0.025 | -0.03 | -0.26 | -0.37 |
| % Growth | 17.4% | 88.5% | 29.7% | – |
| EPS Diluted | -0.025 | -0.03 | -0.26 | -0.37 |
| Weighted Avg Shares Out | 1,021 | 827 | 562 | 405 |
| Weighted Avg Shares Out Dil | 1,021 | 827 | 562 | 405 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $5 | $4 |
| Interest Expense | $25 | $21 | $17 | $14 |
| Depreciation & Amortization | $18 | $20 | $144 | $30 |
| EBITDA | $15 | $6 | -$13 | $11 |
| % Margin | 12.8% | 5.8% | -11.8% | 6.6% |